Cyclerion Therapeutics to Discuss CY6463 MELAS Clinical Data at a Webinar Hosted by UMDF
Cyclerion Therapeutics to Discuss CY6463 MELAS Clinical Data at a Webinar Hosted by United Mitochondrial Disease Foundation Company to...
Read moreLatest News -Press Room
Advocacy Update – April 2022
White House Releases Fiscal Year (FY) 2023 Budget Request – Big Proposed Increases for Research On Monday, March 28, 2022, President...
Read moreTK2d Patient Listening Session – January 2022
TK2d Patient Listening Session – Monday, January 31, 2022 Click here for the downloadable PDF of this report. WHAT IS A PATIENT...
Read moreAdvocacy Update – March 2022
Omnibus Bill Includes 151-Day Extension of Telehealth Waivers Earlier this week, President Biden signed a bill to fund the government through...
Read moreUMDF’s 2022 Congressional Outlook
United Mitochondrial Disease Foundation 2022 Congressional Outlook As it reconvenes, Congress faces a packed agenda in a legislative year that...
Read moreLSIC Awards Second Round of Research Grants
Leigh Syndrome International Consortium Awards Second Round of Research Grants The Leigh Syndrome International Consortium, a patient-driven...
Read moreUMDF Elevates TK2d Patient Voices at FDA
UMDF Elevates TK2d Patient Voices at FDA Pittsburgh, PA (January 31, 2021) – The United Mitochondrial Disease Foundation (UMDF) –...
Read moreUMDF Launches WCG CenterWatch iConnect Clinical Trial Finder Tool
UMDF Launches WCG CenterWatch iConnect Clinical Trial Finder Tool Specific to Mitochondrial Disease Pittsburgh, PA (December 15, 2021)...
Read moreAlan Breslow Appointed to UMDF Board of Trustees
(Pittsburgh, PA) The United Mitochondrial Disease Foundation (UMDF) has announced the appointment of Alan Breslow of Cherry Hill, NJ, to its...
Read moreUMDF Financial Statements
Each year, thousands of donors contribute to our mission of support, education, research, and advocacy. In the interest of transparency, UMDF...
Read more